梅州妇科病医生在线咨询(梅州滴虫性阴道炎 危害) (今日更新中)

The Defense Department announced Tuesday that it had awarded 6 million in contracts to build President Donald Trump's much-sought-after border wall with a completion date for these projects of October 2020.A 9 million contract was awarded to the Texas-based company SLSCO Ltd. for the construction of border wall in Santa Teresa, New Mexico which is located in the El Paso sector of the border.A second 7 million contract was awarded to the Montana-based Barnard Construction Company for work in Yuma, Arizona.The contracts were awarded by the US Army Corps of Engineers.Lt. Col. Jamie Davis, a spokesman for the Department of Defense, told CNN that the El Paso sector contract would include the construction of "30-foot bollard fencing and a five-foot anti-climb plate," and that the Yuma Sector project will feature "18-foot bollard fencing and a five-foot anti-climb plate."A spokesperson for the Army Corps of Engineers told CNN last month that the plan was to install 46 miles at El Paso and 11 miles of fencing at Yuma. CNN has reported that DHS had asked the Pentagon for assistance replacing existing vehicle barriers with pedestrian fencing, as well as light installation in El Paso and Yuma.These are the first border wall contracts to use Pentagon funds that the Trump administration had repurposed from other Defense Department accounts to support the border wall.CNN 1401

The next full moon will appear in the sky this weekend. The full moon will appear “opposite” the sun at 5:17 p.m. EDT Sunday and it will appear full from Saturday morning to Tuesday morning, 203

The federal government’s Real ID Act goes fully into effect next fall which will change the acceptable form of ID required to pass through airport security, regardless of your flight’s destination.Passed by Congress in 2005, the Real ID Act requires every air traveler 18 years or older to have an ID marked with a star located in the upper portion of the card.The Real ID Act enacted the 9/11 Commission’s recommendation that establishes specific federal requirements for state-issued driver license and identification cards.American passengers who do not have a Real ID-compliant license will need to show 620

The opioid crisis cost the U.S. economy 1 billion from 2015 through last year — and it may keep getting more expensive, according to a study released Tuesday by the Society of Actuaries.The biggest driver of the cost over the four-year period is unrealized lifetime earnings of those who died from the drugs, followed by health care costs.While more than 2,000 state and local governments have sued the drug industry over the crisis, the report released Tuesday finds that governments bear less than one-third of the financial costs. The rest of it affects individuals and the private sector.The federal government is tracking how many lives are lost to the opioid crisis (more than 400,000 Americans since 2000), but pinning down the financial cost is less certain.A U.S. Centers for Disease Control and Prevention report from found the cost for 2013 at billion. That’s less than half the cost that the latest report has found in more recent years. The crisis also has deepened since 2013, with fentanyl and other strong synthetic opioids contributing to a higher number of deaths. Overall, opioid-related death numbers rose through 2017 before leveling off last year at about 47,000.A study published in 2017 by the White House Council of Economic Advisers estimated a far higher cost — just over 0 billion a year. The new study notes that the White House one used much higher figures for the value of lives lost to opioids — attempting to quantify their economic value rather than just future income.The actuaries’ report is intended partly to help the insurance industry figure out how to factor opioid use disorder into policy pricing.It found that the cost of the opioid crisis this year is likely to be between 1 billion and 4 billion. Even under the most optimistic scenario, the cost would be higher than it was in 2017.The study was released just ahead of the first federal trial on the opioid crisis, scheduled to start next week in Cleveland where a jury will hear claims from Ohio’s Cuyahoga and Summit counties against six companies. The counties claim the drug industry created a public nuisance and should pay.The report found that criminal justice and child-welfare system costs have been pushed up by the opioid epidemic.Most of the added health care costs for dealing with opioid addiction and overdoses were borne by Medicaid, Medicare and other government programs, according to the report. Still, the crisis rang up billion in commercial insurance costs last year. Lost productivity costs added another billion.Businesses have begun noticing. Last week, a small West Virginia home improvement company, Al Marino Inc., filed a class-action lawsuit against several companies, claiming the opioid crisis was a reason its health insurance costs were skyrocketing.Still, the biggest cost burden fell on families due to lost earnings of those who died. Those mortality costs alone came to more than billion last year, the report said.Members of a committee representing unsecured creditors helping guide opioid maker Purdue Pharma’s bankruptcy process have been calling for money in any settlement to go toward to people affected by the crisis and not just governments. 3225

The Food and Drug Administration has announced a recall of Drospirenone and Ethinyl Estradiol tablets that may have missing or incorrect tablet arrangement.That's birth control, and the announcement says the patient taking these pills might not get the correct dosage if consumed according to the packaging."To date, no case has been reported for pregnancy and adverse event to Apotex," the recall says."Patients who have received impacted lots of Drospirenone and Ethinyl Estradiol Tablets, USP 3MG/0.03MG. or have questions regarding this recall please contact your pharmacy. Individuals should not interrupt their therapy, use a non-hormonal method of birth control, contact their health care provider for medical advice and may return the impacted packages to their pharmacist."Drospirenone and Ethinyl Estradiol Tablets, USP are an estrogen/progestin COC indicated for use by women to prevent pregnancy. Drospirenone and ethinyl estradiol tablets (inner carton) consists of 28 film-coated, biconvex tablets in the following order: 21 yellow color tablets, each containing 3 mg drospirenone (DRSP) and 0.03 mg ethinyl estradiol (EE), and 7 placebo white color tablets."These birth control pills were distributed nationwide to wholesalers and distributors. Patients should consult their doctors. Distributors are asked to return affected products to the place of purchase.Customers who purchased the impacted product directly from Apotex may call GENCO at 1(877) 674-2082 to arrange for their return.Consumers with questions regarding this recall can contact Apotex corp. by phone-number (800) 706-5575or email 1626

来源：资阳报